Clinical Trial Update: Epothilone in Recurrent Glioblastoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update for epothilone in recurrent glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Epothilone (epothilone)

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED